Peter Devilee

60.4k citations

223 papers · 19.1k · 5 hit papers · h-index 61

Impact in

Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Genetics top 0.1%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities

Papers in

Genetics 128
- BRCA gene mutations in cancer 96
- Genomic variations and chromosomal abnormalities 39
Molecular Biology 85
- DNA Repair Mechanisms 20

Co-authors: Fattaneh A. Tavassoli (1 shared paper)Cees J. Cornelisse (68 shared papers)Jean‐Pierre Bayley (24 shared papers)Peter E.M. Taschner (9 shared papers)Cornelisse Cj (17 shared papers)Rama Modali (1 shared paper)Thomas W. Glover (1 shared paper)Bert Vogelstein (2 shared papers)
Journals: European Journal of Human Genetics (10 papers)International Journal of Cancer (10 papers)Human Mutation (10 papers)Genes Chromosomes and Cancer (10 papers)Journal of Medical Genetics (8 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Peter Devilee

218 papers receiving 18.4k citations

Peter Devilee's Hit Papers

5 papers align trajectories log scale

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk 2015 · 611 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 New England Journal of Medicine
2009 Science
2003 Pathology and Genetics of Tumours of the Breast and Female Genital Organs
2000 Science
1989 Nature

Peers

Countries citing papers authored by Peter Devilee

Since Specialization

Citations

This map shows the geographic impact of Peter Devilee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Devilee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Devilee more than expected).

Fields of papers citing papers by Peter Devilee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Devilee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Devilee. The network helps show where Peter Devilee may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Devilee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Devilee Line = papers co-authored together Peter Devilee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutations in the p53 gene occur in diverse human tumour types Nature ·Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger, J. Milburn Jessup, Richard Hosteller, Karen R. Cleary, Sandra H. Signer, Nancy E. Davidson, Stephen Baylin, Peter Devilee, Thomas W. Glover, Francis S. Collins, Ainsley Weslon, Rama Modali, Curtis C. Harris, Bert Vogelstein Hit paper breakdown →	1989	2458
2	Pathology and Genetics of Tumours of the Breast and Female Genital Organs Fattaneh A. Tavassoli, Peter Devilee Hit paper breakdown →	2003	2295
3	Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma Science ·Bora E. Baysal, Robert E. Ferrell, Joan E. Willett-Brozick, Elizabeth Lawrence, David Myssiorek, Anne Marie Bosch, Andel van der Mey, Peter E.M. Taschner, Wendy S. Rubinstein, Eugene N. Myers, (unknown), Cees J. Cornelisse, Peter Devilee, Bernie Devlin Hit paper breakdown →	2000	1356
4	Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk New England Journal of Medicine ·Douglas F. Easton, Paul D.P. Pharoah, Antonis C. Antoniou, Marc Tischkowitz, Sean V. Tavtigian, Katherine L. Nathanson, Peter Devilee, Alfons Meindl, Fergus J. Couch, Melissa C. Southey, David E. Goldgar, D. Gareth Evans, Georgia Chenevix‐Trench, Nazneen Rahman, Mark E. Robson, Susan M. Domchek, William D. Foulkes Hit paper breakdown →	2015	611
5	SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma Science ·Huai‐Xiang Hao, Oleh Khalimonchuk, Margit Schraders, Noah Dephoure, Jean‐Pierre Bayley, Henricus P. M. Kunst, Peter Devilee, Cor W. R. J. Cremers, Joshua D. Schiffman, Brandon G. Bentz, Steven P. Gygi, Dennis R. Winge, Hannie Kremer, Jared Rutter Hit paper breakdown →	2009	577
6	In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors Histochemistry and Cell Biology ·Anton H. N. Hopman, F C Ramaekers, Anton K. Raap, J. L. M. Beck, Peter Devilee, M. van der Ploeg, G. Peter Vooijs	1988	412
7	Instability of short tandem repeats (microsatellites) in human cancers Nature Genetics ·Richard Wooster, A.M. Cleton-Jansen, Nadine Collins, Jonathan Mangion, R.S. Cornelis, Christopher S. Cooper, B A Gusterson, B. A. J. Ponder, Andreas von Deimling, O. D. Wiestler, Cees J. Cornelisse, Peter Devilee, Michael R. Stratton	1994	354
8	Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 The Lancet ·L.C. Verhoog, CTM Brekelmans, Caroline Seynaeve, LMC van den Bosch, G Dahmen, AN van Geel, MMA Tilanus-Linthorst, CCM Bartels, Anja Wagner, A. van den Ouweland, Peter Devilee, E.J. Meijers-Heijboer, J.G.M. Klijn	1998	351
9	BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients Nature Genetics ·Anne Petrij-Bosch, Tamara Peelen, Margreethe van Vliet, Ronald van Eijk, Renske Olmer, Marion Drüsedau, Frans B.L. Hogervorst, S. Hageman, Petronella J.W. Arts, Marjolijn J. L. Ligtenberg, Hanne Meijers-Heijboer, Jan G.M. Klijn, Hans F. A. Vasen, Cees J. Cornelisse, Laura J. van’t Veer, Egbert Bakker, Gert‐Jan B. van Ommen, Peter Devilee	1997	331
10	Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84 Human Genetics ·Thomas Cremer, J. E. Landegent, Andrea Brückner, H. Schöll, Margit Schardin, H. D. Hager, Peter Devilee, P. Pearson, M. van der Ploeg	1986	321
11	Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Molecular and Cellular Biology ·Marc J. van de Vijver, R van de Bersselaar, Peter Devilee, Cornelisse Cj, Johannes L. Peterse, Roel Nusse	1987	310
12	Rapid detection of BRCA1 mutations by the protein truncation test Nature Genetics ·Frans B.L. Hogervorst, Renée S. Cornelis, Mattie Bout, Margreethe van Vliet, Jan C. Oosterwijk, Renske Olmer, Egbert Bakker, Jan G.M. Klijn, Hans F. A. Vasen, Hanna Meijers-Heijboer, Fred H. Menko, Cees J. Cornelisse, Johan T. den Dunnen, Peter Devilee, Gert‐Jan B. van Ommen	1995	261
13	Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation The Lancet ·E.J. Meijers-Heijboer, L.C. Verhoog, CTM Brekelmans, Caroline Seynaeve, MMA Tilanus-Linthorst, Anja Wagner, Lenno Dukel, Peter Devilee, AMW van den Ouweland, AN van Geel, J.G.M. Klijn	2000	237
14	An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. PubMed ·S A Narod, Deborah Ford, Peter Devilee, Rósa B. Barkardóttir, Henry T. Lynch, Simon A. Smith, B. A. J. Ponder, Barbara L. Weber, JudyE. Garber, J.M. Birch	1995	220
15	Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. PubMed ·Peter Devilee, R.F. Thierry, Tim Kievits, Raghu Kolluri, Anton H. N. Hopman, H F Willard, P. Pearson, Cornelisse Cj	1988	214
16	ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility The American Journal of Human Genetics ·Annegien Broeks, Jos Urbanus, Arno Floore, Ellen C. Dahler, Jan G.M. Klijn, Emiel J. Rutgers, Peter Devilee, Nicola S. Russell, Flora E. van Leeuwen, Laura J. van’t Veer	2000	196
17	At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma Genomics ·Peter Devilee, Marianne van den Broek, Nel Kuipers-Dukshoorn, Rukmini Kolluri, P. Meera Khan, P. Pearson, Cees J. Cornelisse	1989	183
18	A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter Human Molecular Genetics ·Peter Heutink, Andel G. L. van der Mey, Lodewijk A. Sandkuijl, A. P. G. van Gils, A. Bardoel, Guido J. Breedveld, Margreethe van Vliet, Gert‐Jan B. van Ommen, Cees J. Cornelisse, Ben A. Oostra, Jim L. Weber, Peter Devilee	1992	181
19	Somatic genetic changes in human breast cancer Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Peter Devilee	1994	181
20	Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. PubMed ·Ed Schuuring, Els Verhoeven, Harm van Tinteren, Peterse Jl, B Nunnink, Erik Thunnissen, Peter Devilee, Cornelisse Cj, Marc J. van de Vijver, Mooi Wj	1992	181

About Peter Devilee

Peter Devilee is a scholar working on Genetics, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 223 papers that have together received 19.1k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (96 papers), Genetic factors in colorectal cancer (46 papers), Cancer Genomics and Diagnostics (39 papers), Genomic variations and chromosomal abnormalities (39 papers), Adrenal and Paraganglionic Tumors (34 papers), Cancer-related Molecular Pathways (21 papers), DNA Repair Mechanisms (20 papers) and Cancer, Hypoxia, and Metabolism (20 papers). The work is most often cited by research in Cancer Research (5.6k citations), Genetics (6.2k citations), Pathology and Forensic Medicine (3.2k citations), Oncology (4.5k citations) and Reproductive Medicine (1.0k citations). Peter Devilee has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Fattaneh A. Tavassoli, Cees J. Cornelisse, Jean‐Pierre Bayley, Peter E.M. Taschner, Cornelisse Cj, Rama Modali, Thomas W. Glover, Bert Vogelstein, Janice Nigro and Nancy E. Davidson. Their work appears in journals such as European Journal of Human Genetics, International Journal of Cancer, Human Mutation, Genes Chromosomes and Cancer and Journal of Medical Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Peter Devilee

Impact in

Papers in i

In The Last Decade

Peter Devilee

Peter Devilee's Hit Papers

Peers

Countries citing papers authored by Peter Devilee

Fields of papers citing papers by Peter Devilee

All Works

About Peter Devilee

Explore authors with similar magnitude of impact

Papers in